Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Miller

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Teratology|February 1, 1986
Synergistic interaction of 2,3,7,8,-tetrachlorodibenzo-p-dioxin and hydrocortisone in the induction of cleft palate in miceL S Birnbaum, M W Harris, C P Miller, et al.
Gastroenterology|July 25, 1998
Misexpression of the pancreatic homeodomain protein IDX-1 by the Hoxa-4 promoter associated with agenesis of the cecumR S Heller, D A Stoffers, M A Hussain, et al.
The Journal of Biological Chemistry|January 1, 2001
Integrative signaling by minimal erythropoietin receptor forms and c-KitT J Pircher, J N Geiger, D Zhang, et al.
Experimental Hematology|November 8, 2001
An optimized system for studies of EPO-dependent murine pro-erythroblast developmentD Zhang, M M Johnson, C P Miller, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2000
Synthesis and estrogenic activities of novel 7-thiosubstituted estratriene derivativesC P Miller, I Jirkovsky, B D Tran, et al.
Journal of Medicinal Chemistry|December 1, 1991
Delineating the pharmacophoric elements of huperzine A: importance of the unsaturated three-carbon bridge to its AChE inhibitory activityA P Kozikowski, C P Miller, F Yamada, et al.
Diabetes|February 1, 1997
Reduced insulin, GLUT2, and IDX-1 in beta-cells after partial pancreatectomyD H Zangen, S Bonner-Weir, C H Lee, et al.
Leukemia|March 2, 2012
Evaluating surface erythropoietin receptor in multiple myelomaC P Miller, K Rattray, Y Zhang, et al.
Diabetes|March 17, 1999
The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regenerationA Sharma, D H Zangen, P Reitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and ratsL M Greenberger, T Annable, K I Collins, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Teratology|February 1, 1986
Synergistic interaction of 2,3,7,8,-tetrachlorodibenzo-p-dioxin and hydrocortisone in the induction of cleft palate in miceL S Birnbaum, M W Harris, C P Miller, et al.
Gastroenterology|July 25, 1998
Misexpression of the pancreatic homeodomain protein IDX-1 by the Hoxa-4 promoter associated with agenesis of the cecumR S Heller, D A Stoffers, M A Hussain, et al.
The Journal of Biological Chemistry|January 1, 2001
Integrative signaling by minimal erythropoietin receptor forms and c-KitT J Pircher, J N Geiger, D Zhang, et al.
Experimental Hematology|November 8, 2001
An optimized system for studies of EPO-dependent murine pro-erythroblast developmentD Zhang, M M Johnson, C P Miller, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2000
Synthesis and estrogenic activities of novel 7-thiosubstituted estratriene derivativesC P Miller, I Jirkovsky, B D Tran, et al.
Journal of Medicinal Chemistry|December 1, 1991
Delineating the pharmacophoric elements of huperzine A: importance of the unsaturated three-carbon bridge to its AChE inhibitory activityA P Kozikowski, C P Miller, F Yamada, et al.
Diabetes|February 1, 1997
Reduced insulin, GLUT2, and IDX-1 in beta-cells after partial pancreatectomyD H Zangen, S Bonner-Weir, C H Lee, et al.
Leukemia|March 2, 2012
Evaluating surface erythropoietin receptor in multiple myelomaC P Miller, K Rattray, Y Zhang, et al.
Diabetes|March 17, 1999
The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regenerationA Sharma, D H Zangen, P Reitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and ratsL M Greenberger, T Annable, K I Collins, et al.
Pageof 7